Using TMS to treat methamphetamine addiction
Theta Burst Transcranial Magnetic Stimulation for the Treatment of Methamphetamine Use Disorder
This study tests if Transcranial Magnetic Stimulation (TMS) can help people with methamphetamine addiction by reducing their cravings and urges.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 40 (estimated) |
| Ages | 18 Years to 55 Years |
| Sex | All |
| Sponsor | Carilion Clinic Academic / other |
| Locations | 1 site (Roanoke, Virginia) |
| Trial ID | NCT06372288 on ClinicalTrials.gov |
What this trial studies
This study investigates the effectiveness of Transcranial Magnetic Stimulation (TMS) as a treatment for individuals with Methamphetamine Use Disorder. Participants will be randomly assigned to receive either active TMS or a sham treatment over five consecutive sessions. The study aims to assess whether TMS can reduce cravings and urges associated with methamphetamine use. Both the participants and the study doctors will be blinded to the treatment assignment to ensure unbiased results.
Who should consider this trial
Good fit: Ideal candidates are individuals actively struggling with Methamphetamine Use Disorder who are enrolled in the Carilion Clinic Office Based Addiction Treatment program.
Not a fit: Patients currently dealing with alcohol or benzodiazepine use may not benefit from this study.
Why it matters
Potential benefit: If successful, this treatment could provide a non-invasive option for individuals struggling with methamphetamine addiction.
How similar studies have performed: While TMS has shown promise in treating other substance use disorders, this specific application for methamphetamine use disorder is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Individuals actively struggling with Methamphetamine Use Disorder * Must be currently enrolled in Carilion Clinic Office Based Addiction Treatment (OBAT) program Exclusion Criteria: - Individuals currently struggling with alcohol use and/or benzodiazepine use
Where this trial is running
Roanoke, Virginia
- Carilion Clinic — Roanoke, Virginia, United States (Recruiting)
Study contacts
- Principal investigator: Sooraj John, M.D. — Carilion Clinic
- Study coordinator: Sooraj John, M.D.
- Email: research@carilionclinic.org
- Phone: 540-981-7000
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.